Morgan Stanley Maintains Overweight on Lemonade, Lowers Price Target to $75
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Bob Huang maintains Lemonade (NYSE:LMND) with a Overweight and lowers the price target from $80 to $75.
Morgan Stanley analyst Bob Huang maintains Lemonade (NYSE:LMND) with a Overweight and lowers the price target from $80 to $75.